Rufinamide - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by Biotoscana; Eisai Co Ltd
- Drug Class Amides; Antiepileptic drugs; Fluorobenzenes; Small molecules; Triazoles
- Mechanism of Action Sodium channel antagonists
- USA Patent Applicants EISAI INC
- USA Patents 3
- NDAs 2
- Patent Applications 1,180
Table of Contents
Disclaimer